What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Mild bacterial conjunctivitis can be effectively managed without specific treatment in immune-competent adults, but topical antibacterial therapy can lead to earlier clinical and microbiological remission, and a 5- to 7-day course of a broad-spectrum topical antibiotic is usually effective. When considering treatment, the choice of antibiotic is usually empiric, and there is no clinical evidence suggesting the superiority of any particular antibiotic 1. Some key points to consider when treating bacterial conjunctivitis include:

  • The use of topical antibacterial therapy is associated with earlier clinical and microbiological remission compared with placebo in days 2 to 5 of treatment 1
  • Treatment may reduce transmissibility and allow for an earlier return to school for children
  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotic therapy for treating bacterial conjunctivitis and could be considered when access to antibiotics is limited 1
  • The most convenient or least expensive antibiotic option can be selected, as there is no clinical evidence suggesting the superiority of any particular antibiotic 1 It's essential to weigh the benefits of treatment against the potential risks and consider individual patient factors, such as the severity of symptoms and the presence of any underlying health conditions 1. In terms of specific treatment regimens, a broad-spectrum topical antibiotic can be used for 5-7 days, but the exact choice of medication and duration of treatment should be determined on a case-by-case basis, taking into account the latest evidence and clinical guidelines 1.

From the Research

Treatment Options for Bacterial Conjunctivitis

  • The treatment for bacterial conjunctivitis typically involves the use of topical antibiotics, which can help to decrease the duration of the infection and allow for an earlier return to normal activities 2, 3.
  • Fluoroquinolones, such as ciprofloxacin, have been shown to be effective in the treatment of bacterial conjunctivitis, but should be reserved for severe infections due to their broad spectrum of activity 2, 4.
  • Other antibiotics, such as gentamycin, tobramycin, and azithromycin, may also be effective in the treatment of bacterial conjunctivitis 2, 5.
  • In some cases, treatment with artificial tears and eye bathings may be considered, especially if the infection is mild and there is a high likelihood of spontaneous healing 2, 3.

Considerations for Treatment

  • The development of bacterial resistance to antibiotics is a concern, and the choice of antibiotic should be guided by the suspected or confirmed causative organism and its antibiotic sensitivity pattern 2, 6, 4.
  • The use of topical antibiotics should be tailored to the specific needs of the patient, taking into account factors such as the severity of the infection, the presence of any underlying medical conditions, and the potential for antibiotic resistance 2, 3, 6.
  • In cases of conjunctivitis caused by sexually transmitted diseases, such as chlamydia or gonorrhea, systemic treatment in addition to topical antibiotic therapy may be necessary 3.

Specific Antibiotics and Their Efficacy

  • Azithromycin 1.5% eye drops have been shown to be effective and well-tolerated in the treatment of bacterial conjunctivitis, with sustained high tissue levels and a low risk of resistance 5.
  • Ciprofloxacin, chloramphenicol, and rifampin have been shown to be active against the most prevalent pathogens in bacterial conjunctivitis, including Haemophilus influenzae and Streptococcus pneumoniae 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Bacterial conjunctivitis--diagnosis and therapy update].

Klinische Monatsblatter fur Augenheilkunde, 2012

Research

[Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].

Anales de pediatria (Barcelona, Spain : 2003), 2004

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.